DIPAM introduces "milestone payments" in RFP; the legal advisors were earlier supposed to get their fee "after successful and satisfactory completion of the transaction"
The other two co-founders, Amod Malviya and Sujeet Kumar, as Board members will actively work with Gupta to ensure the company effectively transitions to a CEO-led structure
The B2B e-commerce platform looks at becoming a publicly listed entity in the next 18-24 months.
The 30-day lock-in period for anchor investors ends on Monday for all the four companies
The Bangalore-headquartered company could close the pre-IPO fundraising in a few weeks at a valuation of about $21 billion
10 investment banks to divide fee pool; opt to go out-of-pocket
The company expects that in the post-COVID-19 environment there will be faster absorption of internet-based activities in the domains where it operates
SoftBank-backed Oyo is eyeing valuation range of $14 bn-$16 bn, say sources close to the development
The bankers include Goldman Sachs (India) Securities, Citigroup Global Markets India, BofA Securities, JP Morgan India
The development comes ahead of proposed initial public offering by OYO, for which a draft red herring prospectus is likely to be filed in the next few months
The sale, which is set to be the country's biggest, could value the company at as much as $261 billion, surpassing Reliance Industries Ltd.
Business Standard brings you the top headlines of the day
The government is also in the process of selling up to 25 per cent stake in National Seeds Corporation (NSC) through IPO
The average applications for IPOs in July stood at 2.6 million, while that in August was about a million, said bankers.
Recently, Snapdeal said it saw huge traction in the sale of kids' apparel, a jump of 493 per cent in the sixth month period between January and July
The initial public offer of specialty chemicals maker Ami Organics was subscribed 64.54 times on the closing day of subscription on Friday
The BSE MidCap index closed 0.35 per cent higher after hitting a new peak of 24,454 in the intra-day deals
Ami is a pharma-focused specialty chemicals firm; Vijaya Diagnostic is among the largest diagnostic chains in southern India
In new tender, DIPAM specifies three-year time limit for validity of the financial bids
While Ami is a pharma-focused specialty chemicals firm, Vijaya Diagnostic is among the largest diagnostic chains in southern India